Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Robinson

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Journal of Synchrotron Radiation|May 13, 2025
Optimizing a photon absorber using conformal cooling channels and additive manufacturing in copperYounes Chahid, Carolyn Atkins, Stephen Hodbod, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatmentDean S Elterman, Anika R Petrella, Lauren M Walker, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Journal of Medicinal Chemistry|March 12, 2025
Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH TreatmentsMaria-Eleni Kouridaki, Jonathan Gillespie, John Robinson, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomesHanwen Zhang, Daniel Kargilis, Thomas Tropea, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2015
T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute MelioidosisCatherine Reynolds, Amélie Goudet, Kemajittra Jenjaroen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Trials|August 12, 2025
The COMBAT Project: study protocol for the development of a core outcome set for morbidity following surgery in paediatric brain tumour patientsSandhya Trichinopoly Krishna, Nicola Harman, Conor Mallucci, et al.
ACS Chemical Biology|June 18, 2025
High-Throughput Screening of Potent Drug-like Molecules Targeting 17β-HSD10 for the Treatment of Alzheimer's Disease and CancerLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Journal of Synchrotron Radiation|May 13, 2025
Optimizing a photon absorber using conformal cooling channels and additive manufacturing in copperYounes Chahid, Carolyn Atkins, Stephen Hodbod, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatmentDean S Elterman, Anika R Petrella, Lauren M Walker, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Journal of Medicinal Chemistry|March 12, 2025
Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH TreatmentsMaria-Eleni Kouridaki, Jonathan Gillespie, John Robinson, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomesHanwen Zhang, Daniel Kargilis, Thomas Tropea, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2015
T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute MelioidosisCatherine Reynolds, Amélie Goudet, Kemajittra Jenjaroen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Trials|August 12, 2025
The COMBAT Project: study protocol for the development of a core outcome set for morbidity following surgery in paediatric brain tumour patientsSandhya Trichinopoly Krishna, Nicola Harman, Conor Mallucci, et al.
ACS Chemical Biology|June 18, 2025
High-Throughput Screening of Potent Drug-like Molecules Targeting 17β-HSD10 for the Treatment of Alzheimer's Disease and CancerLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Pageof 21